|
aTyr Pharma Inc
|
United States |
1 Oct 2010 |
Series C
Active |
|
|
|
aTyr Pharma Inc
|
United States |
1 Apr 2007 |
Series B
Active |
|
|
|
Avid Radiopharmaceuticals Inc
|
United States |
1 May 2009 |
Series D
Active |
|
|
|
Azelon Pharmaceuticals Inc
|
United States |
|
N/A
|
|
|
|
Be Inc
|
United States |
|
N/A
|
|
|
|
Bioventus LLC
Leading orthopedic biologics company |
United States |
|
N/A
|
|
|
|
Blaze Software Inc
|
United States |
|
N/A
|
|
|
|
Calistoga Pharmaceuticals Inc
Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. |
United States |
|
N/A
|
|
|
|
Callisto Pharmaceuticals Inc
Public biotechnology company that develops novel therapeutics to treat cancer. |
United States |
|
N/A
Active |
|
|
|
Cara Therapeutics Inc
|
United States |
|
N/A
|
|
|
|
Carbylan BioSurgery Inc
|
United States |
|
N/A
|
|
|
|
Celetronix USA
|
United States |
|
N/A
|
|
|
|
Cellective Therapeutics Inc
|
United States |
|
N/A
|
|
|
|
Cellomics Inc
|
United States |
|
N/A
|
|
|
|
Ceregene Inc
Biotechnology company focused on the development and commercialization of gene therapies for the treatment of neurological disorders. |
United States |
|
N/A
|
|
|
|
Cerenis Therapeutics SA
|
France |
|
N/A
|
|
|
|
Chemgenex Pharmaceuticals Ltd
|
Australia |
|
N/A
|
|
|
|
ChemoCentryx Inc
|
United States |
|
N/A
|
|
|
|
Chimerix Inc
|
United States |
1 Feb 2011 |
Series F
|
|
|
|
Chimerix Inc
|
United States |
1 Aug 2009 |
Series E
|
|